CHAMPAIGN, Ill. (WCIA) — Epilepsy is a brain condition that causes recurring seizures and impacts one in 26 people in the United States. For the second year, the Epilepsy Advocacy Network hosted its ...

Leigh syndrome is a rare metabolic disorder that begins in childhood and causes severe neurological and muscular problems. The disease has long been considered untreatable. In a pilot study involving ...

Xenon Pharmaceuticals climbed by 31.7 percent week-on-week, as investor sentiment was bolstered by positive clinical trial ...

Discover how ultra-early epilepsy surgeries transform the lives of children with drug-resistant seizures, preventing long-term brain damage.

Researchers have discovered that an existing drug could be the breakthrough cure for a condition impacting 30 million people in the US, which until now has had no pharmaceutical options.

A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the ...

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

Dravet syndrome affects about 1 in 17,500 children. Having two daughters with the condition is “extraordinarily uncommon.” ...

When people think about epilepsy, dramatic scenes often come to mind. A person collapsing, shaking violently, or losing consciousness. Films and telev.

Published in The Lancet Neurology, a new review from the University of Colorado Anschutz in collaboration with UT Southwestern Medical Center, offers the latest scientific explanations for why ...

Ketogenic diet therapies, including the classic ketogenic diet, modified Atkins diet, and low glycaemic index treatment, have ...